The Use of Fluphenazines in a Continuing-Care Program
Abstract
The author describes his experience in using long-acting injectable fluphenazines with chronic schizophrenic patients in a continuing-care program in San Diego County. He has found the drug to be economical, long-lasting in therapeutic effect, and less likely than other drugs to produce serious side-effects, particularly tardive dyskinesia. In addition, use of injectables makes it possible to avoid depending on untrained operators of residential facilities to see that the patients take their drugs.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
